Joshua Fredell, SVP, Pharmacy Services, shares insights on this biologic drug and why it matters. 

• Our history of innovation at CVS Caremark demonstrates that we are uniquely positioned to positively impact the market.

• Members feel supported when their prescription plan prioritizes affordability, and their biosimilars are backed by regulatory approval for safety and efficacy, Joshua notes. 

• "If we remain focused on driving to lower-cost products and using our technology to make that even easier for everyone involved, we will be able to maximize the savings potential that biosimilars provide," Joshua says.